wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.
P2860
Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45957917-5F7122C7-D667-44CB-A075-5A4705138B03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94da0fe1a63476d3df52960b9a55b1a222e3d802
P2860
Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosis.